Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
4,858.00
4,565.00
3,890.00
3,688.00
3,070.00
3,315.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
4,858.00
4,565.00
3,890.00
3,688.00
3,070.00
3,315.00
Expenditure (Ex Depriciation)
Stock Adjustments
38.00
-184.00
43.00
-2.00
95.00
-353.00
Raw Materials Consumed
1,920.00
2,163.00
1,705.00
1,629.00
1,407.00
1,686.00
Power & Fuel Cost
66.00
58.00
75.00
85.00
71.00
64.00
Employee Cost
928.00
862.00
737.00
732.00
646.00
550.00
Operating Expenses
391.00
302.00
296.00
250.00
240.00
209.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
357.00
298.00
215.00
263.00
331.00
223.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
-36.00
41.00
37.00
37.00
51.00
49.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
3,933.00
3,762.00
3,307.00
3,258.00
3,090.00
2,681.00
Operating Profit (PBDIT) excl Other Income
925.00
802.00
582.00
430.00
-20.00
634.00
Other Income
150.00
58.00
39.00
90.00
131.00
51.00
Operating Profit (PBDIT)
1,076.00
861.00
622.00
520.00
111.00
686.00
Interest
178.00
248.00
280.00
261.00
176.00
150.00
Profit before Depriciation and Tax
897.00
612.00
341.00
259.00
-64.00
536.00
Depreciation
202.00
192.00
213.00
243.00
233.00
206.00
Profit Before Taxation & Exceptional Items
695.00
420.00
128.00
16.00
-297.00
329.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
668.00
486.00
-114.00
-286.00
-652.00
275.00
Provision for Tax
94.00
77.00
29.00
-55.00
-178.00
31.00
Profit After Tax
574.00
407.00
-89.00
54.00
-363.00
341.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
458.00
-284.00
-200.00
2.00
484.00
234.00
Profit Available for appropriations
1,015.00
120.00
-320.00
-218.00
24.00
488.00
Appropriations
1,015.00
120.00
-320.00
-218.00
24.00
488.00
Equity Dividend (%)
50.00%
40.00%
25.00%
15.00%
0.00%
25.00%
Earnings Per Share
60.34
390.55
-7.76
-22.49
-51.28
29.96
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 6.43% vs 17.36% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 15.26% vs 37.85% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -28.25% vs -11.20% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 40.85% vs 553.17% in Mar 2025
Compare Profit and Loss Results of Strides Pharma
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
4,858.00
819.00
4,039.00
493.16%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
4,858.00
819.00
4,039.00
493.16%
Expenditure (Ex Depriciation)
Stock Adjustments
38.00
-43.00
81.00
188.37%
Raw Materials Consumed
1,920.00
528.00
1,392.00
263.64%
Power & Fuel Cost
66.00
62.00
4.00
6.45%
Employee Cost
928.00
69.00
859.00
1,244.93%
Operating Expenses
391.00
32.00
359.00
1,121.88%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
357.00
23.00
334.00
1,452.17%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
-36.00
5.00
-41.00
-820.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
3,933.00
708.00
3,225.00
455.51%
Operating Profit (PBDIT) excl Other Income
925.00
111.00
814.00
733.33%
Other Income
150.00
30.00
120.00
400.00%
Operating Profit (PBDIT)
1,076.00
141.00
935.00
663.12%
Interest
178.00
16.00
162.00
1,012.50%
Profit before Depriciation and Tax
897.00
125.00
772.00
617.60%
Depreciation
202.00
33.00
169.00
512.12%
Profit Before Taxation & Exceptional Items
695.00
91.00
604.00
663.74%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
668.00
91.00
577.00
634.07%
Provision for Tax
94.00
-3.00
97.00
3,233.33%
Profit After Tax
574.00
95.00
479.00
504.21%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
458.00
-2,268.00
2,726.00
120.19%
Profit Available for appropriations
1,015.00
-2,176.00
3,191.00
146.65%
Appropriations
1,015.00
-2,176.00
3,191.00
146.65%
Equity Dividend (%)
50%
0%
50.00
Earnings Per Share
60.34
19.06
41.28
216.58%
Profit And Loss - Net Sales
Net Sales 4,858.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 6.43% vs 17.36% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 925.29 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 15.26% vs 37.85% in Mar 2025
Profit And Loss - Interest
Interest 178.54 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -28.25% vs -11.20% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 574.05 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 40.85% vs 553.17% in Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
